Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
N. Tufon, Emmanuel
- Correlating the Prevalence and Severity of Anaemia amongst HIV Infected Adults Males and Females Attending the Bamenda Regional Hospital, Cameroon
Abstract Views :276 |
PDF Views:2
Authors
Affiliations
1 Department of Medical Biochemistry, St Louis University Institute of Health and Biomedical Sciences, Mile Three Nkwen Bamenda, CM
1 Department of Medical Biochemistry, St Louis University Institute of Health and Biomedical Sciences, Mile Three Nkwen Bamenda, CM
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 4, No 4 (2012), Pagination: 225-227Abstract
Anaemia is an independent risk factor for disease progression and death in persons with HIV infection. The prevalence and severity of anaemia was therefore correlated amongst 300 Cameroonian adult males and females who were diagnosed with the HIV infection at the Bamenda Regional Hospital. Four different haemoglobin concentrations were used as cut off points to categorize anaemia into mild anaemia (Hb ≤ 10g/dl); clear - cut anaemia (Hb ≤ 9g/dl); severe anaemia (Hb ≤ 7g/dl) and critically severe anaemia (Hb ≤ 5g/dl). A cell - Dyn 3200 blood analyzer was used to determine the haemoglobin concentration of the different groups of patients. Results obtained showed that the mean haemoglobin concentration of the HIV infected males (10.08 ± 0.4g/dl) significantly decreased (p<0.05) compared to the mean haemoglobin concentration of the HIV free control (14.0 ± 0.14g/dl). The mean haemoglobin concentration of the HIV infected females (8.76 ± 10.5g/dl) also decreased significantly (p<0.05) compared to the HIV free control (12.1 ± 0.8g/dl). The prevalence of mild anaemia, clear - cut anaemia, severe anaemia and critically severe anaemia were 43.3%, 40%, 4.7% and 0% in males and 25.3%, 60%, 4.7% and 10% in females respectively. The results obtained from this study indicates that the severity of anaemia in higher in HIV infected adult females than adult males attending the Bamenda Regional Hospital.Keywords
Anaemia, Severity, Prevalence, HIV, Cameroon.References
- • Alumanah, E.O and Nwanguma, B.C. (2007). Severity of anaemia in Nigerian children diagnosed with plasmodium facilparium malaria in the first year of life. Journal of Rural and Tropical Public Health. 6:11 - 15
- • De Maeyer, E.M and Adeils - Tryman, M. (1985). The prevalence of anaemia in the world. World Health Quarterly 38:302 - 316
- • De Marchi, S., Pirisi, M and Ferraccioli, G. (1993). Erythropoietin and the anaemia of chronic diseases. Clin Exp Rhematol. 11:429 - 444
- • Galloway, R. (2003). Anaemia, prevention and control: what works, part I programme Guidance. Population, Health and Nutrition Information Project. Washington, D.C
- • Gordeux, V., Delanghe, J, Langlois, M and Boelaert, J. (2001). Iron states and the outcome of HIV infection. An overview. J.Clin Virol. 34:27 - 33
- • Graeme, M. (2002). Anaemia in Persons with HIV infection: Prognostic Marker and Contributor of Morbidity. AIDS Rev 4:13 - 20
- • Groopman, J. (1998). Fatigue in Cancer and HIV/AIDS. Oncology 12:335 - 44
- • Ludwig, H and Strasser, K. (2002). Symptomatology of anaemia. Semin Oncol 28:7 - 14
- • Moore, R and Forney, D. (2002). Anaemia in HIV infected patients receiving highly active antiretroviral therapy. J.Acquired Immune Defic Syndrome. 29: 29 - 57
- • Sobrero, A., Puglisi, F and Guglielmi, A. (2001). Fatigue: a main component of anaemia. Symptomatology Semin Oncol 28:15 - 18
- • Volberding, P. (2000). Consensus statement: anaemia in HIV infection - current trends treatment options and practice strategies, Anaemia in HIV working Group. Clin Ther 22:1004 - 1020
- • Walker, R., Parker, R and Kovacs, J. (1988). Anaemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi Sarcoma treated with Zidovudine. Ann Intern Med 108:372 - 376
- • WHO (2001). The strength of the evidence linking Iron deficiency anaemia to health and development outcomes. J of Nutr Supplements. 131
- • WHO (2006). WHO: case definition of HIV for surveillance and revised clinical staging and Immunological classification.